2734878-16-9
Chemical Structure
INX-SM-6
- CAS. Nr.: 2734878-16-9
- Formula:C32H36N2O6S
- Molecular Weight:576.70
IUPAC Name: (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-(2-(3-aminobenzyl)thiazol-5-yl)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
InChIKey: NJJMSRHGOQXBCC-CIIJGLHGSA-N
SMILES: O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@H]5O)(O[C@@](C(S6)=CN=C6CC7=CC(N)=CC=C7)([H])O1)[C@]2(C5)C)CO
Biological Activity: INX-SM-6 can be used for targeted delivery of anti-inflammatory agent. INX-SM-6 inhibits LPS-induced IL-1β production in human PBMCS[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
INX-SM-6 | 98.85% | INX-SM-6 can be used for targeted delivery of anti-inflammatory agent. INX-SM-6 inhibits LPS-induced IL-1β production in human PBMCS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
